Key result
Pre-procedural spontaneous shunting is not associated with higher residual shunting after PFO closure.
Why the study?
The pre-procedural shunt pattern on contrast transthoracic echocardiography may reflect anatomical complexity, and whether these shunt characteristics are associated with residual shunting at 6 months after percutaneous PFO closure was uncertain.
Does a pre-procedural spontaneous shunt pattern increase the risk of residual shunting at 6 months compared to a Valsalva-only shunt pattern in patients undergoing percutaneous PFO closure?
Cohort (n=443)
Does a pre-procedural spontaneous shunt pattern increase the risk of residual shunting at 6 months compared to a Valsalva-only shunt pattern in patients undergoing percutaneous PFO closure?
Pre-procedural shunt pattern and size on contrast transthoracic echocardiography do not predict 6-month residual shunting after percutaneous PFO closure, whereas larger closure device size is independently associated with increased residual shunting.
Purpose Contrast transthoracic echocardiography (cTTE) is used to assess the presence and size of a shunt in patients suspected of a patent foramen ovale (PFO), both during normal breathing and the Valsalva manoeuvre. The shunt pattern on cTTE, shunt at rest or shunt only during Valsalva, may reflect anatomical complexity and thereby influence the risk of residual shunting. This study aimed to determine whether pre-procedural shunt characteristics are associated with the presence of residual shunting at 6 months after percutaneous PFO closure. Methods In this retrospective cohort study, patients undergoing percutaneous PFO closure between 2005 and 2024 were included. Patients were divided in two groups based on the initial, pre-procedural cTTE, with group A consisting of patients with a spontaneous shunt and group B consisting of patients with a shunt that was only present during the Valsalva manoeuvre. The presence of any residual shunting between group A and B was compared using the Χ2-test. A multivariable logistic regression was performed to assess the association between shunt pattern and residual shunting at 6 months, correcting for pre-procedural shunt size (graded as small/medium/large based on cTTE) and size of the closure device. Results Of the included patients, 443 patients had available data of the pre-procedural cTTE and the primary outcome of residual shunting at 6 months. A residual shunt was present at 6 months in 37.7% of the patients in group A and 33.3% of the patients in group B (P = 0.41). In the multivariable logistic regression, adjusted for pre-procedural shunt size and device size, no association was observed between pre-procedural spontaneous shunting and residual shunting at 6 months (OR 1.22, 95% CI; 0.77-1.98). The pre-procedural shunt size was not associated with residual shunting, whereas a larger device size was independently associated (OR 1.17, 95% CI; 1.10-1.26). Conclusion In this study the pre-procedural shunt pattern and size were not associated with residual shunting at 6 months. The size of the closure device emerged as an independent predictor of residual shunting, suggesting the features of the closure device in relation to the surrounding structures may play a more prominent role in residual shunting than initial shunt characteristics.
No takes yet. Share an insight, caveat, or question.
Nieuwendijk et al. (2026) conducted a cohort in Patent foramen ovale (PFO) undergoing percutaneous closure (n=443). Pre-procedural spontaneous shunt on contrast transthoracic echocardiography (Group A) vs. Pre-procedural shunt present only during Valsalva manoeuvre (Group B) was evaluated on Residual shunting at 6 months after percutaneous PFO closure (OR 1.22, 95% CI 0.77-1.98, p=0.41). Pre-procedural spontaneous shunting on cTTE was not associated with residual shunting at 6 months post-PFO closure vs Valsalva-only shunting (37.7% vs 33.3%; OR 1.22, 95% CI 0.77-1.98).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: